The expression of these biomarkers is highly variable between tumors, with ER/PR positive cells ranging from 1 to 100 percent, where a frequency of stained cells higher than 1% in tumor biopsy is considered a cutoff for ER/PR positivity. This evidence concerns the gene ESR1 and neoplasm.